{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Adial Pharmaceuticals, Inc"},"Symbol":{"label":"Symbol","value":"ADIL"},"Address":{"label":"Address","value":"1180 SEMINOLE TRAIL SUITE 495, CHARLOTTESVILLE, Virginia, 22901, United States"},"Phone":{"label":"Phone","value":"+1 434 422-9800"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder."},"CompanyUrl":{"label":"Company Url","value":"https://www.adialpharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Bankole A. Johnson","title":"Chief Medical Officer"},{"name":"Julien Dimastromatteo","title":"Vice President-Research"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}